Poorva Bindal to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Poorva Bindal has written about Randomized Controlled Trials as Topic.
Connection Strength
0.162
-
Bindal P, Najjar M, Koehn K, Godara A, Sborov DW, McClune B, Julian K, Wagner C, Mohyuddin GR. Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials. Leuk Lymphoma. 2023 Jul-Aug; 64(7):1340-1343.
Score: 0.162